Volitionrx ltd (vnrx) product pipeline analysis, 2016 update

Research focused on the VolitionRX Ltd. (VNRX) ­ Product Pipeline Analysis, 2016 Update "The Report VolitionRX Ltd. (VNRX) ­ Product Pipeline Analysis, 2016 Update provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. ­ MarketResearchReports.biz" VolitionRX Ltd. (VolitionRX) is a life science company that develops diagnostic solutions.

The company develops blood­based diagnostic tests for detecting and diagnosing cancer and other diseases. It provides ELISA diagnostic technology with nucleosome detection and analysis techniques. VolitionRX develops tests on the basis of Nucleosomics biomarker platform, designed to identify and measure nucleosomes in the bloodstream or other bodily fluid. The company has developed epigenetic NuQ assays to detect cancer by detecting nucleosomes containing specific nucleotides, modified histones, specific histone variants, nucleosome­protein adducts and total blood nucleosome levels. The company has its presence in Belgium. VolitionRX is headquartered in Singapore.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Download Sample copy of this Report @ http://www.marketresearchreports.biz/sample/sample/772253 Scope: ­ The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments ­ The report analyzes all pipeline products in development for the company VolitionRX Ltd. ­ The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) ­ The report covers detailed information on each pipeline product with information on

pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date ­ The report provides detailed description of products in development, technical specification and functions ­ The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy: ­ Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape ­ Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio ­ To formulate effective Research & Development strategies ­ Develop market­entry and market expansion strategies ­ Exploit in­licensing and out­licensing opportunities by identifying products, most likely to ensure a robust return ­ Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline ­ Identify emerging players with potentially strong product portfolio and create effective counter­strategies to gain competitive advantage ­ Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc ­ Identify, understand and capitalize the next high­value products that your competitor would add in its portfolio Table of Content : Table of Contents 2 List of Tables 5 List of Figures 7 VolitionRX Ltd. Company Snapshot 8 VolitionRX Ltd. Company Overview 8 VolitionRX Ltd. Pipeline Products and Clinical Trials Overview 9 VolitionRX Ltd. Pipeline Analysis Overview 11 Key Facts 11 VolitionRX Ltd. ­ Major Products and Services 12 VolitionRX Ltd. Pipeline Products by Development Stage 13 VolitionRX Ltd. Clinical Trials by Trial Status 17 VolitionRX Ltd. Pipeline Products Overview 19 Colorectal Cancer Panel Test 19

Colorectal Cancer Panel Test Product Overview 19 HyperGenomics Diagnostic Test ­ Colon Cancer 20 HyperGenomics Diagnostic Test ­ Colon Cancer Product Overview 20 HyperGenomics Diagnostic Test ­ Leukaemia 21 HyperGenomics Diagnostic Test ­ Leukaemia Product Overview 21 HyperGenomics Diagnostic Test ­ Prostate Cancer 22 HyperGenomics Diagnostic Test ­ Prostate Cancer Product Overview 22 NuQ ­ A Androgen Receptor Cell Culture ELISA Kit 23 NuQ ­ A Androgen Receptor Cell Culture ELISA Kit Product Overview 23 NuQ ­ A EZH2 Cell Culture ELISA Kit 24 NuQ ­ A EZH2 Cell Culture ELISA Kit Product Overview 24 NuQ ­ A HMGB1 Cell Culture ELISA Kit 25 NuQ ­ A HMGB1 Cell Culture ELISA Kit Product Overview 25 NuQ ­ A Oestrogen Receptor Cell Culture ELISA Kit 26 NuQ ­ A Oestrogen Receptor Cell Culture ELISA Kit Product Overview 26 NuQ ­ A Progesterone Receptor Cell Culture ELISA Kit 27 NuQ ­ A Progesterone Receptor Cell Culture ELISA Kit Product Overview 27 NuQ ­ Prostate Cancer 28 NuQ ­ Prostate Cancer Product Overview 28 NuQ ­ Prostate Cancer Clinical Trial 29 NuQ ­ T 30 About us MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact us: Mr. Nachiket 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1­518­618­1030 USA: Canada Toll Free: 866­997­4948 Website: http://www.marketresearchreports.biz/ E : sales@marketresearchreports.biz